Leading long COVID researcher, Akiko Iwasaki, PhD, sterling professor of immunobiology at Yale University, joins to provide an update on the latest long COVID studies and clinical trials—and what their findings mean for physicians and patients. Dr. Iwasaki discusses what we know now about the causes of long COVID, the ongoing challenges with diagnosing it and the timeline for potential treatments. American Medical Association CXO Todd Unger hosts.
00:00 AMA Update for Nov. 30, 2023 01:04 Understanding long COVID (Post-COVID conditions) 01:32 What is long COVID? 04:46 Causes of long COVID (autoimmunity, hyper coagulation, inflammation, reactivation of herpes virus) 02:18 Long COVID studies (post-acute infection syndrome) 02:45 Chronic fatigue syndrome and what triggers myalgic encephalomyelitis ME/CFS 02:57 Long COVID definition 03:56 New long COVID research 04:32 Cortisol and long COVID: Does COVID affect your cortisol levels? 04:46 Latent herpes virus and reactivation of Epstein-Barr 05:48 Serotonin and long COVID symptoms (SARS-CoV-2) 07:02 COVID antiviral medication 07:36 Long COVID clinical trials 08:00 Long COVID test: Are there diagnostic tests for long Covid? 08:19 Long COVID diagnosis 09:05 Long COVID treatment and therapeutics 09:52 Does Paxlovid reduce long term COVID? 10:13 What is the best treatment for long Covid? 11:09 Monoclonal antibody treatment for COVID 12:11 Is long covid permanent?
